Regarding MPM-diagnosis, the use of fluorescence in situ hybridization to detect the homozygous deletion of CDKN2A proved helpful to distinguish between malignant mesothelial cells and benign reactive mesothelial cells both in pleural effusion and tissue samples [26, 27]. The gene discussed is CDKN2A; the disease is Pleural effusion.